Literature DB >> 6090349

Oestradiol-BSA conjugates for receptor histochemistry: problems of stability and interactions with cytosol.

M Binder.   

Abstract

The validity of histochemical methods for the localization of hormone receptors based on the binding of fluorescent bovine serum albumin conjugates of oestradiol was examined with respect to their stability and their interactions with the oestrogen receptor type I. Stability was assessed by measuring free oestrogen in conjugates by radioimmunoassay and/or receptor protein binding assay. Sufficient free oestrogen--in order to saturate type I and type II binding sites (ER I, ER II)--was detected in freshly prepared conjugates. This free oestrogen originates in inadequate removal of adsorptively bound original ligand after synthesis. Apart from this fact, conjugates appeared to be unstable in aqueous solutions, especially under the conditions used for for histochemical methods. Free oestrogen extracted from the conjugates was subjected to high performance liquid chromatography. Amongst the eluted peaks, oestradiol and/or the original ligand used for synthesis were identified. The in vitro interaction of conjugates with oestrogen receptors was studied by competitive binding analysis and by incubation of cytosol with a Sepharose-bound conjugate. The results, especially those concerning the amount of free oestrogen, suggest that neither ER I nor ER II is involved in the staining mechanism of conjugates.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6090349     DOI: 10.1007/bf01003854

Source DB:  PubMed          Journal:  Histochem J        ISSN: 0018-2214


  60 in total

1.  Differences in staining of normal and malignant cells by non-immune fluorescent protein conjugates.

Authors:  R C NAIRN; H G RICHMOND; J E FOTHERGILL
Journal:  Br Med J       Date:  1960-11-05

2.  Autoradiographic techniques for localizing steroid hormones.

Authors:  W E Stumpf; M Sar
Journal:  Methods Enzymol       Date:  1975       Impact factor: 1.600

3.  Competitive binding assay for estradiol receptor using immobilized antibody.

Authors:  J Fishman; J H Fishman
Journal:  J Clin Endocrinol Metab       Date:  1974-09       Impact factor: 5.958

4.  Conjugation of antibodies with fluorochromes: modifications to the standard methods.

Authors:  J W Goding
Journal:  J Immunol Methods       Date:  1976       Impact factor: 2.303

5.  Fluorescence labeling method for estimation of soluble polymers in the living material.

Authors:  F Rypácek; J Drobník; J Kálal
Journal:  Anal Biochem       Date:  1980-05-01       Impact factor: 3.365

6.  Identification of estrogen-inducible growth factors (estromedins) for rat and human mammary tumor cells in culture.

Authors:  T Ikeda; Q F Liu; D Danielpour; J B Officer; M Iio; F E Leland; D A Sirbasku
Journal:  In Vitro       Date:  1982-12

7.  Immunohistochemical detection of an estrogen-regulated protein by monoclonal antibodies.

Authors:  D R Ciocca; D J Adams; R J Bjercke; D P Edwards; W L McGuire
Journal:  Cancer Res       Date:  1982-10       Impact factor: 12.701

8.  Comparison of biochemical and histochemical techniques for estrogen receptor analyses in mammary carcinoma.

Authors:  K S McCarty; B H Woodard; D E Nichols; W Wilkinson; K S McCarty
Journal:  Cancer       Date:  1980-12-15       Impact factor: 6.860

9.  Lack of correlation of a histochemical method for estrogen receptors analysis with the biochemical assay results.

Authors:  W B Panko; C A Mattioli; T M Wheeler
Journal:  Cancer       Date:  1982-05-15       Impact factor: 6.860

10.  Purification and characterization of creatine kinase, an estrogen-induced uterine protein (IP) from immature rats.

Authors:  S A Kumar; D L O'Connor; J I Seeger; T A Beach; H W Dickerman
Journal:  Biochem Biophys Res Commun       Date:  1983-02-28       Impact factor: 3.575

View more
  6 in total

1.  Mitogen activated protein kinase (MAPK) mediates non-genomic pathway of estrogen on T cell cytokine production following trauma-hemorrhage.

Authors:  Takao Suzuki; Huang-Ping Yu; Ya-Ching Hsieh; Mashkoor A Choudhry; Kirby I Bland; Irshad H Chaudry
Journal:  Cytokine       Date:  2008-03-14       Impact factor: 3.861

Review 2.  International Union of Basic and Clinical Pharmacology. XCVII. G Protein-Coupled Estrogen Receptor and Its Pharmacologic Modulators.

Authors:  Eric R Prossnitz; Jeffrey B Arterburn
Journal:  Pharmacol Rev       Date:  2015-07       Impact factor: 25.468

Review 3.  Proteins of multiple classes may participate in nongenomic steroid actions.

Authors:  Cheryl S Watson; Bahiru Gametchu
Journal:  Exp Biol Med (Maywood)       Date:  2003-12

4.  The membrane actions of estrogens can potentiate their lordosis behavior-facilitating genomic actions.

Authors:  Lee-Ming Kow; Donald W Pfaff
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-09       Impact factor: 11.205

5.  The PI3K/Akt pathway mediates the nongenomic cardioprotective effects of estrogen following trauma-hemorrhage.

Authors:  Huang-Ping Yu; Ya-Ching Hsieh; Takao Suzuki; Mashkoor A Choudhry; Martin G Schwacha; Kirby I Bland; Irshad H Chaudry
Journal:  Ann Surg       Date:  2007-06       Impact factor: 12.969

6.  Membrane estrogen receptor-alpha levels in MCF-7 breast cancer cells predict cAMP and proliferation responses.

Authors:  Dragoslava Zivadinovic; Bahiru Gametchu; Cheryl S Watson
Journal:  Breast Cancer Res       Date:  2004-11-24       Impact factor: 6.466

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.